Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes.
about
New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharidesMoxifloxacin modulates inflammation during murine pneumonia.Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.Phage ΦPan70, a Putative Temperate Phage, Controls Pseudomonas aeruginosa in Planktonic, Biofilm and Burn Mouse Model AssaysHost-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure.Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model.Study of macrophage functions in murine J774 cells and human activated THP-1 cells exposed to oritavancin, a lipoglycopeptide with high cellular accumulation.Effect of Different Antibiotic Chemotherapies on Pseudomonas aeruginosa Infection In Vitro of Primary Human Corneal Fibroblast Cells.A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms.Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation.Pharmacodynamics of ceftazidime/avibactam against extracellular and intracellular forms of Pseudomonas aeruginosa.Antibacterial Activity of 1-[(2,4-Dichlorophenethyl)amino]-3-Phenoxypropan-2-ol against Antibiotic-Resistant Strains of Diverse Bacterial Pathogens, Biofilms and in Pre-clinical Infection Models.
P2860
Q28654498-87D2EEF9-6F5C-48E9-8F65-58C305DD516CQ33986123-BC6A77CD-909C-4A5F-AA42-EBD8C12F6AF1Q34922363-1565A857-FB51-40F9-8011-67B2A54A4267Q35860120-9293E44F-A3F8-40D4-8FC9-6EA35A90857FQ36076253-E01616D3-5C14-416D-B244-00B286208109Q36106267-B79AD0BA-9B34-4958-B36E-4533CF16775EQ38325843-D068745E-9AEC-4AED-8AF2-D7DAE8CBA8D5Q39031976-DDF71E75-7360-4BFB-AD69-802E5DF551B0Q40063500-54E7E535-78AF-4780-8E4D-046A044E4B1BQ40112398-AD2B6711-94FA-47B8-807E-0DD1F2E89FE9Q40257063-24F05639-0026-420B-9228-E79FD8A0E29EQ40614488-402BF108-A622-42E5-A0A1-0C95EAEF2B5DQ47991463-BECA6CCE-9EC4-4F46-B590-1ACAF391BCD8Q49182957-9A7442B1-311E-4ED3-B549-14158544CDBC
P2860
Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pharmacodynamic evaluation of ...... odel of THP-1 human monocytes.
@en
type
label
Pharmacodynamic evaluation of ...... odel of THP-1 human monocytes.
@en
prefLabel
Pharmacodynamic evaluation of ...... odel of THP-1 human monocytes.
@en
P2093
P2860
P50
P356
P1476
Pharmacodynamic evaluation of ...... model of THP-1 human monocytes
@en
P2093
Françoise Van Bambeke
Julien M Buyck
Paul M Tulkens
P2860
P304
P356
10.1128/AAC.02609-12
P407
P577
2013-03-11T00:00:00Z